FDA Fully Approves Pfizer/BioNTech Vaccine (Comirnaty)

The FDA grants full approval (beyond Emergency Use Authorization) to the Pfizer/BioNTech COVID-19 vaccine for individuals 16 and older under the brand name Comirnaty — the first COVID-19 vaccine to receive full FDA approval. This accelerates vaccine mandates by employers and institutions.